Objectives: 

1.  Understand biologics' role in escalating health care expenditures in the U.S.

2.  Compare and contrast the features of the small molecule-generic and biologic-biosimilar relationships.

3.  Evaluate barriers to biosimilar market penetration and individual prescribing.